Eledon Pharmaceuticals, Inc.

NASDAQ:ELDN

2.99 (USD) • At close June 9, 2025
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

2025 Q12024 Q42024 Q32024 Q22024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32020 Q22020 Q12019 Q42019 Q32019 Q22019 Q12018 Q42018 Q32018 Q22018 Q12017 Q42017 Q32017 Q22017 Q12016 Q42016 Q32016 Q22016 Q12015 Q42015 Q32015 Q22015 Q12014 Q42014 Q32014 Q22014 Q12013 Q42013 Q3
Revenue 00.1920000.56000000000000.120.120000000000000000000000000000
Cost of Revenue 0000.0970.0950.0940.0940.0940.0920.0930.0930.0940.0930.0610.0440.0440.0460000000000000000000.0010.0010.003000000000
Gross Profit 00.1920-0.097-0.0950.466-0.094-0.094-0.092-0.093-0.093-0.094-0.093-0.061-0.044-0.044-0.0460.120.120000000000000000-0.001-0.001-0.003000000000
Gross Profit Ratio 010000.8320000000-507.333000110000000000000000000000000000
Reseach & Development Expenses 13.53117.92816.5210.1067.417.0677.9317.2018.1137.257.4525.7436.6356.1827.6584.2425.6533.0360.6150.8321.6481.3331.5092.2972.9892.741.6511.3291.0970.4930.5170.5330.3061.0366.1629.8957.9317.7338.4915.85510.5593.8042.8254.3923.5564.3492.704
General & Administrative Expenses 4.4336.7683.994.3963.4593.2713.2673.1532.9972.793.1463.543.2243.2032.8483.7293.3523.3223.7311.2691.730.9671.4111.7921.8861.8371.8481.861.69810.232.4486.1333.5862.7243.1463.683.5493.3393.4163.1272.7412.4573.5991.4931.3361.20.661
Selling & Marketing Expenses 0000-0.095-0.09400000000000000000000000-8.61800000000000000000
SG&A 4.4336.7683.994.3963.3643.1773.2673.1532.9972.793.1463.543.2243.2032.8483.7293.3523.3223.7311.2691.730.9671.4111.7921.8861.8371.8481.861.6981.6122.4486.1333.5862.7243.1463.683.5493.3393.4163.1272.7412.4573.5991.4931.3361.20.661
Other Expenses 00000.5740.7120.8490.7750.3380.3040.1270.036-0.00500.003-0.0010.0050.040.0040.0050.030.0230.027-0.004-0.0060.0030.0030-0.011-0.005-0.0050.0040.0110-0.418-0.07000000.0530.0340000
Operating Expenses 17.96424.69620.5114.50210.77410.24411.19810.35411.1110.0410.5989.2839.8599.38510.5067.9719.0056.3584.3462.1013.3782.32.924.0894.8754.5773.4993.1892.7952.1052.9656.6663.8923.769.30813.57511.4811.07211.9078.98213.36.2616.4245.8854.8925.5493.365
Operating Income -17.964-24.504-20.51-14.502-10.869-10.338-11.198-10.354-11.11-58.688-10.598-9.283-9.859-9.385-10.506-7.971-9.005-6.348-6.148-2.591-3.378-4.167-2.92-4.089-4.875-4.577-3.499-3.189-2.795-2.105-2.965-6.666-3.892-3.76-9.308-13.575-11.48-11.072-11.907-8.982-13.3-6.261-6.424-5.885-4.892-5.549-3.365
Operating Income Ratio 0-127.625000-18.4610000000-78,208.333000-52.9-51.2330000000000000000000000000000
Total Other Income Expenses Net 11.469-19.68297.481-30.405-12.7620.7120.849-55.4060.3380.3040.1270.036-0.00500.003-0.0010.0050.040.0040.005-4.7990.0230.027-0.004-0.0060.0030.0030-0.011-0.005-0.0050.0040.0260.0230.0380.0490.0540.0550.0540.0250.040.0530.0340.0340.0450.0240
Income Before Tax -6.495-44.18676.971-44.907-10.295-9.626-10.349-9.579-10.772-58.384-10.471-9.247-9.864-9.385-10.503-7.972-9-6.308-6.144-2.586-8.177-4.144-2.893-4.093-4.881-4.574-3.496-3.189-2.806-2.11-2.97-6.662-3.866-3.737-9.27-13.526-11.426-11.017-11.853-8.957-13.26-6.208-6.39-5.851-4.847-5.525-3.365
Income Before Tax Ratio 0-230.135000-17.1890000000-78,208.333000-52.567-51.20000000000000000000000000000
Income Tax Expense 0-0.431000.0520.050.134-0.028-0.338-0.335-0.127-0.0360.005-0.579-0.686-0.588-0.501-0.4141.8020.494.8290000000000.005-0.003000000000-0.058-0.0390000
Net Income -6.495-44.61776.971-44.907-10.295-9.626-10.349-9.579-10.434-58.049-10.344-9.211-9.869-8.806-9.817-7.384-8.499-5.904-6.144-2.586-8.177-4.144-2.893-4.093-4.881-4.574-3.496-3.189-2.806-2.11-2.97-6.662-3.866-3.737-9.27-13.526-11.426-11.017-11.853-8.957-13.26-6.208-6.39-5.851-4.847-5.525-3.365
Net Income Ratio 0-232.38000-17.1890000000-73,383.333000-49.2-51.20000000000000000000000000000
EPS -0.081.04-0.34-1.06-0.34-0.4-0.35-0.4-0.73-4.21-0.73-0.65-0.69-0.62-0.66-0.5-0.57-8.19-5.51-2.74-8.52-5.75-4.01-6.27-9.32-8.74-6.68-6.1-6.52-5.47-7.7-28.86-168.24-26.74-2,051.79-3,127.4-81.81-79.18-85.19-64.72-95.97-45.04-439.18-45.65-51.13-1,814.45-1,105.09
EPS Diluted -0.080.1-0.32-1.06-0.34-0.4-0.35-0.4-0.73-4.21-0.73-0.65-0.69-0.59-0.66-0.5-0.57-8.19-5.51-2.74-8.52-5.75-4.01-6.27-9.32-8.74-6.68-6.1-6.52-5.47-7.7-28.86-168.24-26.74-2,051.79-3,127.4-81.81-79.18-85.19-64.72-95.97-45.04-439.18-45.65-51.13-1,814.45-1,105.09
EBITDA -17.964-24.608-20.431-14.405-10.774-10.244-11.104-10.26-11.018-9.947-10.505-9.189-9.766-9.324-10.462-7.927-8.959-6.263-5.379-2.099-3.332-2.298-2.874-4.044-4.83-4.574-3.496-3.187-2.792-2.106-2.968-6.662-1.381-3.72-9.308-0.922-11.427-11.125-11.875-8.966-13.295-6.256-6.419-5.878-4.888-5.546-3.361
EBITDA Ratio 0-128.167000-18.2930000000-77,700000-52.192-44.8250000000000000000000000000000